2017
DOI: 10.1016/j.bioorg.2017.01.006
|View full text |Cite
|
Sign up to set email alerts
|

Dihydropyrimidinone-isatin hybrids as novel non-nucleoside HIV-1 reverse transcriptase inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
27
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(27 citation statements)
references
References 21 publications
0
27
0
Order By: Relevance
“…Isatin, 1,2,3‐triazole, and coumarin possess a variety of biological and pharmacological properties such as antitubercular , antibacterial , antiviral , antimalarial and anticancer activities, occupying an important position in the development of new drugs. Several isatin‐based or 1,2,3‐triazole or coumarin‐based compounds such as semaxanib, carboxyamidotriazole, and STX64 (Fig.…”
Section: Introductionmentioning
confidence: 99%
“…Isatin, 1,2,3‐triazole, and coumarin possess a variety of biological and pharmacological properties such as antitubercular , antibacterial , antiviral , antimalarial and anticancer activities, occupying an important position in the development of new drugs. Several isatin‐based or 1,2,3‐triazole or coumarin‐based compounds such as semaxanib, carboxyamidotriazole, and STX64 (Fig.…”
Section: Introductionmentioning
confidence: 99%
“…Among heterocyclic compounds, isatin‐based, 1,2,3‐triazole‐based, and coumarin‐based compounds have broad biological activity spectrum including antitubercular , antibacterial , antiviral , antimalarial , and anticancer properties. Moreover, some of them such as sunitinib, carboxyamidotriazole, and STX64 (Fig.…”
Section: Introductionmentioning
confidence: 99%
“…Isatin and triazole derivatives possess diverse biological and pharmacological properties such as antitubercular , antibacterial , antiviral , antimalarial , and anticancer activities, occupying an important position in the drug discovery. Several isatin‐ or triazole‐based compounds such as sunitinib, nintedanib, semaxanib, and carboxyamidotriazole (Fig.…”
Section: Introductionmentioning
confidence: 99%